Keywords: barr, shares, fall, disappointing, 1st, qtr, pharmaceuticals
Barr shares fall 15% on disappointing 1st qtr
Article | 19 May 2008
Shares in Barr Pharmaceuticals fell 15% in premarket trading on May 8, after the US generics giant reported disappointing first-quarter 2008 profit and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
